We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Nelarabine.
- Authors
Gandhi, Varsha; Keating, Michael J.; Bate, Guy; Kirkpatrick, Peter
- Abstract
In October 2005, nelarabine (Arranon; GlaxoSmithKline), a nucleoside analogue, was given accelerated approval by the US FDA for the treatment of patients with T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma whose disease has not responded to treatment or has relapsed following treatment with at least two chemotherapy regimens.
- Subjects
NEW product development; DRUGS; LEUKEMIA treatment; LYMPHOBLASTIC leukemia; LYMPHOMAS; GLAXOSMITHKLINE
- Publication
Nature Reviews Drug Discovery, 2006, Vol 5, Issue 1, p17
- ISSN
1474-1776
- Publication type
Article
- DOI
10.1038/nrd1933